Johnson & Johnson Trims Full-Year Guidance on Stronger Dollar

Johnson & Johnson cut its full-year sales and profit guidance, as a stronger U.S. dollar hits results of the healthcare-products company.

The New Brunswick, N.J.-based company now sees full-year sales up between 2.1% and 3.1%, down from a prior guidance of 3.8% to 4.8%. Adjusted earnings for the year are expected to grow between 2.1% and 3.1%, down from 3.6% to 5.6%. Johnson & Johnson said on Tuesday that the lowered view is largely due to the stronger dollar.

 » Read More  » Read More

Tags: No tags

Comments are closed.